cnto 3649
Recombinant proteinexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00882726)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- cnto 3649
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02224118 | Phase 1 | Jul 1, 2009 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT00882726 | Phase 1 | Feb 1, 2009 | Centocor |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centocor | For profit | 1 | 1 | 1 | 2009 |
| Janssen Pharmaceutica NV | For profit | 1 | 0 | 1 | 2009 |
| Johnson and Johnson | For profit | 1 | 1 | 1 | 2009 |
3 organizations
Page 1 / 1